Tech Center 1600 • Art Units: 1622 1624 1656
This examiner grants 67% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18449807 | TREATMENT OF BREAST CANCER USING COMBINATION THERAPIES COMPRISING GDC-9545 AND IPATASERTIB | Non-Final OA | Genentech, Inc. |
| 18449793 | TREATMENT OF BREAST CANCER USING COMBINATION THERAPIES COMPRISING GDC-9545 AND ABEMACICLIB OR RIBOCICLIB | Final Rejection | Genentech, Inc. |
| 18709395 | Prodrugs of Neurosteroid Analogs and Uses Thereof | Non-Final OA | Emory University |
| 18685544 | PYRAZINE COMPOUNDS FOR THE CONTROL OF INVERTEBRATE PESTS | Non-Final OA | BASF SE |
| 18602132 | METHODS FOR TREATING CYTOKINE STORM ASSOCIATED WITH ACINETOBACTER BAUMANNII INFECTIONS | Final Rejection | City University of Hong Kong |
| 18562666 | METHOD FOR CRYSTALLIZATION OF AROMATIC AMINO ACIDS, ENABLING SUSTAINABLE CYCLE OF AMMONIA | Final Rejection | CJ CheilJedang Corporation |
| 18293683 | INHIBITORS OF HYPOXIA-INDUCIBLE FACTORS | Non-Final OA | The Johns Hopkins University |
| 18335687 | DIHYDROOXADIAZINONE COMPOUND AND PHARMACEUTICAL USE THEREOF | Final Rejection | Japan Tobacco Inc. |
| 18219447 | PROCESS FOR PREPARING PHOSPHONATE ESTERS | Final Rejection | ENTEGRIS, INC. |
| 18293766 | PROCESS FOR PREPARING A OXACYLOHEXANE OR OXACYLOPENTANE DERIVATIVE | Final Rejection | Firmenich SA |
| 18293768 | PROCESS FOR PREPARING A OXACYLOHEXANE OR OXACYLOPENTANE DERIVATIVE | Final Rejection | Firmenich SA |
| 18284515 | PROCESS FOR THE PREPARATION OF CYCLEN | Final Rejection | SERICHIM SRL |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy